On The Pen: The Weekly Dose 8.20.24
Listen now
Description
Send us a textVOTE FOR THE WEEKLY DOSE PODCAST!CHECK OUT OUR SPONSOR: RO.CO/OTPSemaglutide in Parkinsons and Opiod Abusehttps://www.wired.com/story/the-benefits-of-ozempic-are-multiplying/?How Roche Passed on Orforglipronhttps://www.swissinfo.ch/eng/multinational-companies/how-roche-passed-on-a-potential-14bn-a-year-weight-loss-pill/86877239?fbclid=IwZXh0bgNhZW0CMTEAAR1doDlsWIFXuUJYA9Kz75D9VvzZycgqm2kVbVPuWWFgOP0tvOVNvIWluVY_aem_GDMhnl8sQEVePWYy0XdheQRoche's Obesity Pipelinehttps://www.onthep...
More Episodes
Send us a textIn this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare options. This week’s deep dive also touches on...
Published 11/12/24
Send us a textSemaglutide News: https://www.onthepen.com/post/select-trial-update-semaglutide-s-cardiovascular-benefits-and-psychiatric-safety-profile-highlighteViking Therapeutics News:https://www.onthepen.com/post/vk2735-vikingtideAstraZeneca News:...
Published 11/05/24
Published 11/05/24